Tumor Response Predicts Survival Time of Ramucirumab Plus Irinotecan in Advanced Gastric Cancer: An Exploratory Analysis of the Phase III RINDBeRG Trial

Toshifumi Yamaguchi, Hiroki Yukami, Hiroyuki Kodama, Yoshihiro Okita, Takeshi Shiraishi, Daisuke Kobayashi, Kiyoshi Ishigure, Ko Takachi, Shunji Endo, Toshio Shimokawa, Daisuke Sakai, Taroh Satoh

ESMO 2025, Berlin, Germany 17 – 21 Oct 2025